Efectos de la Estimulación Cognitiva en la Enfermedad de Alzheimer: Implicación de BDNF

Education and cognitive occupations is commonly associated to reduced risk of Alzheimer¿s disease (AD) dementia. Animal studies have demonstrated that cognitive stimulation (CS) achieved by social/physical activities and/or enriched environments compensates for memory decline. We have elaborated a n...

Full description

Bibliographic Details
Main Authors: Gereñu-Lopetegi, G. (Gorka), Ramirez, M.J. (María Javier), Gil-Bea, F.J. (Francisco J.)
Format: info:eu-repo/semantics/doctoralThesis
Language:spa
Published: 2016
Subjects:
Online Access:https://hdl.handle.net/10171/40604
_version_ 1793400524025888768
author Gereñu-Lopetegi, G. (Gorka)
Ramirez, M.J. (María Javier)
Gil-Bea, F.J. (Francisco J.)
author_facet Gereñu-Lopetegi, G. (Gorka)
Ramirez, M.J. (María Javier)
Gil-Bea, F.J. (Francisco J.)
author_sort Gereñu-Lopetegi, G. (Gorka)
collection DSpace
description Education and cognitive occupations is commonly associated to reduced risk of Alzheimer¿s disease (AD) dementia. Animal studies have demonstrated that cognitive stimulation (CS) achieved by social/physical activities and/or enriched environments compensates for memory decline. We have elaborated a novel paradigm of CS that is devoid of physical/social activity and enriched environments. 4 months-old Tg2576 mice were cognitively trained for 8 weeks and, after a break of 8 months, long-lasting effects of CS on cognitive abilities and AD-like pathology were measured. MWM and NOR tests showed that deficits in spatial and recognition memories were compensated by CS. These outcomes were accompanied by increased levels of hippocampal post-synaptic markers (PSD95 and NR1) and proteins involved in synaptic formation (Arc, â-catenin). CS softened amyloid pathology in terms of reduced levels of Aâ1-42 and the dodecameric assembly, referred as Aâ*56. CS appeared to affect the APP processing since differences in levels of ADAM17, BACE1 and C99/C83 ratio were found. Tau hyper-phosphorylation and high activities of Tau kinases were also reduced by CS. In contrast, CS did not induce any of these molecular changes in wild-type mice. The present findings suggest beneficial and long-lasting effects of CS early in life on cognitive decline and AD-like pathology. In this research work we have also characterized the role of BDNF on a new mechanism by which cognitive stimulation exerts its beneficial effects on cognitive decline and AD-like pathology.
format info:eu-repo/semantics/doctoralThesis
id oai:dadun.unav.edu:10171-40604
institution Universidad de Navarra
language spa
publishDate 2016
record_format dspace
spelling oai:dadun.unav.edu:10171-406042020-03-03T13:08:03Z Efectos de la Estimulación Cognitiva en la Enfermedad de Alzheimer: Implicación de BDNF Gereñu-Lopetegi, G. (Gorka) Ramirez, M.J. (María Javier) Gil-Bea, F.J. (Francisco J.) Materias Investigacion::Ciencias de la Salud Neurobiología molecular Education and cognitive occupations is commonly associated to reduced risk of Alzheimer¿s disease (AD) dementia. Animal studies have demonstrated that cognitive stimulation (CS) achieved by social/physical activities and/or enriched environments compensates for memory decline. We have elaborated a novel paradigm of CS that is devoid of physical/social activity and enriched environments. 4 months-old Tg2576 mice were cognitively trained for 8 weeks and, after a break of 8 months, long-lasting effects of CS on cognitive abilities and AD-like pathology were measured. MWM and NOR tests showed that deficits in spatial and recognition memories were compensated by CS. These outcomes were accompanied by increased levels of hippocampal post-synaptic markers (PSD95 and NR1) and proteins involved in synaptic formation (Arc, â-catenin). CS softened amyloid pathology in terms of reduced levels of Aâ1-42 and the dodecameric assembly, referred as Aâ*56. CS appeared to affect the APP processing since differences in levels of ADAM17, BACE1 and C99/C83 ratio were found. Tau hyper-phosphorylation and high activities of Tau kinases were also reduced by CS. In contrast, CS did not induce any of these molecular changes in wild-type mice. The present findings suggest beneficial and long-lasting effects of CS early in life on cognitive decline and AD-like pathology. In this research work we have also characterized the role of BDNF on a new mechanism by which cognitive stimulation exerts its beneficial effects on cognitive decline and AD-like pathology. 2016-05-11T11:20:34Z 2016-05-11T11:20:34Z 2013-04 2013-06-13 info:eu-repo/semantics/doctoralThesis https://hdl.handle.net/10171/40604 spa info:eu-repo/semantics/openAccess application/pdf
spellingShingle Materias Investigacion::Ciencias de la Salud
Neurobiología molecular
Gereñu-Lopetegi, G. (Gorka)
Ramirez, M.J. (María Javier)
Gil-Bea, F.J. (Francisco J.)
Efectos de la Estimulación Cognitiva en la Enfermedad de Alzheimer: Implicación de BDNF
title Efectos de la Estimulación Cognitiva en la Enfermedad de Alzheimer: Implicación de BDNF
title_full Efectos de la Estimulación Cognitiva en la Enfermedad de Alzheimer: Implicación de BDNF
title_fullStr Efectos de la Estimulación Cognitiva en la Enfermedad de Alzheimer: Implicación de BDNF
title_full_unstemmed Efectos de la Estimulación Cognitiva en la Enfermedad de Alzheimer: Implicación de BDNF
title_short Efectos de la Estimulación Cognitiva en la Enfermedad de Alzheimer: Implicación de BDNF
title_sort efectos de la estimulación cognitiva en la enfermedad de alzheimer: implicación de bdnf
topic Materias Investigacion::Ciencias de la Salud
Neurobiología molecular
url https://hdl.handle.net/10171/40604
work_keys_str_mv AT gerenulopetegiggorka efectosdelaestimulacioncognitivaenlaenfermedaddealzheimerimplicaciondebdnf
AT ramirezmjmariajavier efectosdelaestimulacioncognitivaenlaenfermedaddealzheimerimplicaciondebdnf
AT gilbeafjfranciscoj efectosdelaestimulacioncognitivaenlaenfermedaddealzheimerimplicaciondebdnf